all subject must sign an inform consent indicate that they be aware of the investigational nature of this study prior to any study-related procedure patient must be register with in the dana farber cancer institute 's quality assurance office for clinical trial prior to treatment with zd6474 vandetanib patient must sign an authorization for the release of their protect health information 